Literature DB >> 8865348

Expression and crystallization of the yeast Hsp82 chaperone, and preliminary X-ray diffraction studies of the amino-terminal domain.

C Prodromou1, P W Piper, L H Pearl.   

Abstract

Expression of the Saccharomyces cerevisiae Hsp82 chaperone in a pep4-3- and hsc82-deficient strain of S. cerevisiae yielded over 25% of the total cell protein as intact Hsp82. Similarly, the amino-terminal domain (residues 1-220) of Hsp82 was expressed to 18% of the total cell protein. Crystals of the intact Hsp82 were readily obtained. The crystals were very fragile, suggesting a high solvent content, and diffracted to approximately 8 A. Tetragonal bipyrimidal crystals of the amino-terminal domain of Hsp82 were readily obtained under a variety of different conditions. The crystals have primitive tetragonal space group (P422, P4(1)22, or its enantiomorph P4(3)22) with unit cell dimensions of a = 75.1 A and c = 111.3 A, contain 60% by volume solvent, and diffract to 2.5 A resoltuion. Addition of 25% glycerol to the mother liquor gave rise to large rod-shaped crystals. The crystals diffract to 2.8 A resolution, have an orthorhombic space group (P222(1), P2(1)2(1)2, or P2(1)2(1)2(1)) with cell dimensions of a = 45.2 A, b = 115.4 A, and c = 116.9 A, and a solvent content of 58% by volume.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865348     DOI: 10.1002/prot.13

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  8 in total

1.  Molecular chaperones and the assembly of the prion Sup35p, an in vitro study.

Authors:  Joanna Krzewska; Ronald Melki
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

2.  ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo.

Authors:  B Panaretou; C Prodromou; S M Roe; R O'Brien; J E Ladbury; P W Piper; L H Pearl
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

3.  Drosophila glycoprotein 93 Is an ortholog of mammalian heat shock protein gp96 (grp94, HSP90b1, HSPC4) and retains disulfide bond-independent chaperone function for TLRs and integrins.

Authors:  Crystal Morales; Shuang Wu; Yi Yang; Bing Hao; Zihai Li
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

4.  Molecular chaperones and the assembly of the prion Ure2p in vitro.

Authors:  Jimmy Savistchenko; Joanna Krzewska; Nicolas Fay; Ronald Melki
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

Review 5.  Natural product inhibitors of Hsp90: potential leads for drug discovery.

Authors:  M W Amolins; B S J Blagg
Journal:  Mini Rev Med Chem       Date:  2009-02       Impact factor: 3.862

6.  Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones.

Authors:  C Prodromou; G Siligardi; R O'Brien; D N Woolfson; L Regan; B Panaretou; J E Ladbury; P W Piper; L H Pearl
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

7.  Co-crystalization and in vitro biological characterization of 5-aryl-4-(5-substituted-2-4-dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.

Authors:  Swee Y Sharp; S Mark Roe; Egidijus Kazlauskas; Inga Cikotienė; Paul Workman; Daumantas Matulis; Chrisostomos Prodromou
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

8.  Heat shock protein 90 and role of its chemical inhibitors in treatment of hematologic malignancies.

Authors:  Ngoc Ho; Adam Li; Shaoguang Li; Haojian Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2012-07-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.